High-grade Serous Ovarian Carcinoma
📧 Sign up to get email alerts when something new happens for High-grade Serous Ovarian Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) [Phase 2]
Phase 2 trial MK-4830-002 evaluating pembrolizumab with chemotherapy and MK-4830 in ovarian cancer has completed enrollment with results pos…
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating bortezomib with pegylated liposomal doxorubicin in BRCA wild-type platinum-resistant recurrent ovarian can…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Phase II ABT-888 With Cyclophosphamide [Phase 2]
Phase II trial evaluating veliparib (ABT-888) in combination with cyclophosphamide across ovarian and related gynecologic cancers; results w…